Sheaff Brock Investment Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.31M | Buy |
3,125
+89
| +3% | +$38.6K | 0.12% | 146 |
|
|
2024
Q4 | $1.26M | Buy |
3,036
+51
| +2% | +$22.4K | 0.11% | 142 |
|
|
2024
Q3 | $1.51M | Buy |
2,985
+172
| +6% | +$83.6K | 0.13% | 131 |
|
|
2024
Q2 | $1.37M | Sell |
2,813
-228
| -7% | -$114K | 0.13% | 134 |
|
|
2024
Q1 | $1.64M | Buy |
3,041
+192
| +7% | +$105K | 0.1% | 131 |
|
|
2023
Q4 | $1.58M | Buy |
2,849
+103
| +4% | +$48.4K | 0.12% | 123 |
|
|
2023
Q3 | $1.2M | Sell |
2,746
-18
| -0.7% | -$8.98K | 0.11% | 142 |
|
|
2023
Q2 | $1.39M | Sell |
2,764
-31
| -1% | -$14.9K | 0.12% | 131 |
|
|
2023
Q1 | $1.4M | Buy |
2,795
+46
| +2% | +$22K | 0.13% | 129 |
|
|
2022
Q4 | $1.12M | Buy |
2,749
+103
| +4% | +$40K | 0.11% | 149 |
|
|
2022
Q3 | $862K | Buy |
2,646
+3
| +0.1% | +$1.1K | 0.09% | 169 |
|
|
2022
Q2 | $927K | Buy |
2,643
+88
| +3% | +$35.9K | 0.08% | 167 |
|
|
2022
Q1 | $1.4M | Sell |
2,555
-21
| -0.8% | -$11K | 0.1% | 138 |
|
|
2021
Q4 | $1.7M | Buy |
2,576
+142
| +6% | +$89.1K | 0.11% | 123 |
|
|
2021
Q3 | $1.51M | Sell |
2,434
-134
| -5% | -$90K | 0.11% | 132 |
|
|
2021
Q2 | $1.62M | Buy |
2,568
+108
| +4% | +$59.6K | 0.12% | 114 |
|
|
2021
Q1 | $1.2M | Sell |
2,460
-292
| -11% | -$146K | 0.09% | 139 |
|
|
2020
Q4 | $1.38M | Sell |
2,752
-326
| -11% | -$146K | 0.12% | 111 |
|
|
2020
Q3 | $1.21M | Sell |
3,078
-320
| -9% | -$118K | 0.11% | 122 |
|
|
2020
Q2 | $1.12M | Sell |
3,398
-183
| -5% | -$53K | 0.11% | 110 |
|
|
2020
Q1 | $867K | Sell |
3,581
-338
| -9% | -$88.2K | 0.11% | 113 |
|
|
2019
Q4 | $1.02M | Sell |
3,919
-101
| -3% | -$26.6K | 0.1% | 141 |
|
|
2019
Q3 | $1.09M | Sell |
4,020
-117
| -3% | -$32.6K | 0.12% | 125 |
|
|
2019
Q2 | $1.14M | Sell |
4,137
-422
| -9% | -$104K | 0.12% | 120 |
|
|
2019
Q1 | $1.02M | Buy |
4,559
+42
| +0.9% | +$8.67K | 0.12% | 138 |
|
|
2018
Q4 | $840K | Sell |
4,517
-105
| -2% | -$21.5K | 0.13% | 143 |
|
|
2018
Q3 | $1.15M | Sell |
4,622
-728
| -14% | -$177K | 0.11% | 132 |
|
|
2018
Q2 | $1.17M | Sell |
5,350
-165
| -3% | -$34K | 0.11% | 129 |
|
|
2018
Q1 | $1.06M | Buy |
5,515
+97
| +2% | +$17.9K | 0.11% | 140 |
|
|
2017
Q4 | $847K | Sell |
5,418
-260
| -5% | -$40.9K | 0.11% | 179 |
|
|
2017
Q3 | $883K | Sell |
5,678
-398
| -7% | -$62.9K | 0.12% | 169 |
|
|
2017
Q2 | $981K | Buy |
6,076
+243
| +4% | +$39.5K | 0.13% | 154 |
|
|
2017
Q1 | $902K | Buy |
+5,833
| New | +$804K | 0.12% | 167 |
|
Other funds holding IDXX
Sheaff Brock Investment Advisors's IDXX Position: Q1 2025 in Review
Sheaff Brock Investment Advisors increased its Idexx Laboratories (IDXX) stake by 2.9% in Q1 2025, buying an estimated $38.6K and bringing the position to 3,125 shares worth $1.31M. The position accounts for 0.12% of the portfolio, ranked #146.
Sheaff Brock Investment Advisors first reported a position in IDXX in Q1 2017 and has held it in 33 quarters since. The position peaked at $1.7M in Q4 2021. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.
- Sheaff Brock Investment Advisors held 3,125 shares of Idexx Laboratories worth $1.31M as of Q1 2025.
- Sheaff Brock Investment Advisors bought 89 Idexx Laboratories shares in Q1 2025, an estimated $38.6K.
- Idexx Laboratories made up 0.12% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #146 holding.
- Sheaff Brock Investment Advisors first reported a position in Idexx Laboratories in Q1 2017 and has held it in 33 quarters since.
- Sheaff Brock Investment Advisors's Idexx Laboratories position peaked at $1.7M in Q4 2021.
- 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.
Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.